MedPath

High-dose Chemotherapy With Hematopoietic Stem-cell Rescue for High-risk Breast Cancer: Long-term Follow-up

Completed
Conditions
Breast Cancer Female
Registration Number
NCT03087409
Lead Sponsor
University Medical Center Groningen
Brief Summary

Collection of follow-up data from the original trial patient cohort.

Detailed Description

Collection of follow-up data from the original trial patient cohort by means of structured patient file abstraction, a questionnaire to the general practitioner, and registry consultations.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
885
Inclusion Criteria
  • Enrolment in the original trial.
Read More
Exclusion Criteria
  • None.
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Overall survival2 years

Overall survival according to the definition and analysis plan of the original study

Relapse-free survival2 years

Relapse-free survival according to the definition and analysis plan of the original study

Secondary Outcome Measures
NameTimeMethod
Incidence of cardiovascular events2 years
Incidence of malignancies2 years

Trial Locations

Locations (10)

The Netherlands Cancer Institute

🇳🇱

Amsterdam, Netherlands

VU University Medical Center

🇳🇱

Amsterdam, Netherlands

Academic Medical Center

🇳🇱

Amsterdam, Netherlands

University Medical Center Groningen

🇳🇱

Groningen, Netherlands

Maastricht University Medical Center

🇳🇱

Maastricht, Netherlands

Erasmus Medical Center

🇳🇱

Rotterdam, Netherlands

Medisch Spectrum Twente

🇳🇱

Enschede, Netherlands

Radboud University Medical Center

🇳🇱

Nijmegen, Netherlands

Leiden University Medical Center

🇳🇱

Leiden, Netherlands

University Medical Center Utrecht

🇳🇱

Utrecht, Netherlands

© Copyright 2025. All Rights Reserved by MedPath